2018
Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users
Zigler R, Madden T, Ashby C, Wan L, McNicholas C. Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users. Obstetrics And Gynecology 2018, 132: 888-894. PMID: 30130351, PMCID: PMC6153077, DOI: 10.1097/aog.0000000000002810.Peer-Reviewed Original ResearchConceptsEtonogestrel implant usersUlipristal acetateImplant usersIdentical-appearing placeboPlacebo-controlled trialSerum progesterone levelsUnscheduled bleedingBleeding profilePlacebo groupSecondary outcomesEnrolled participantsEligible participantsSerum progesteroneOvulatory potentialProgesterone levelsOvulation statusPlaceboU.S. FoodDemographic characteristicsWomenBleedingParticipant satisfactionEffect sizeDaysGroup
2011
Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial
Madden T, Proehl S, Allsworth J, Secura G, Peipert J. Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial. American Journal Of Obstetrics And Gynecology 2011, 206: 129.e1-129.e8. PMID: 22055339, PMCID: PMC3268863, DOI: 10.1016/j.ajog.2011.09.021.Peer-Reviewed Original ResearchConceptsNaproxen groupIntrauterine systemLevonorgestrel-releasing intrauterine system useLevonorgestrel-releasing intrauterine systemAdministration of naproxenLevonorgestrel intrauterine systemIntrauterine system useOral naproxenEstradiol groupTreat analysisMultivariable analysisLowest quartileFrequent bleedingPlaceboEstradiol decreaseEstradiolTrialsWomenNaproxenDaysGroupBleedingQuartileAdministrationWeeks